You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cGVHD

Showing 326 - 350 of 350
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resistant Chronic GVHD Trial in Jerusalem (Alefacept)

Completed
  • Resistant Chronic GVHD
  • Jerusalem, Israel
    Department of Stem cell Transplantation & Cancer immunotherapy;
Apr 19, 2015

Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in United States (drug, procedure, radiation)

Completed
Has Results
  • Leukemia
  • +2 more
  • Scottsdale, Arizona
  • +5 more
Jan 15, 2015

Oral Chronic Graft-versus-host Disease Trial in Boston (Tacrolimus, Dexamethasone)

Completed
Has Results
  • Oral Chronic Graft-versus-host Disease
  • Boston, Massachusetts
  • +4 more
Feb 24, 2014

Chronic Graft-Versus-Host Disease in Undergone Donor Stem Cell

Terminated
  • Cancer
  • polymorphism analysis
  • laboratory biomarker analysis
  • Nashville, Tennessee
  • +2 more
May 11, 2013

Graft-versus-Host Disease Trial in Houston (Lenalidomide)

Terminated
Has Results
  • Graft-versus-Host Disease
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 21, 2013

Chronic Myeloproliferative Disorders, GVHD, Infection Trial in Phoenix, Duarte (biological, drug, procedure, radiation)

Completed
Has Results
  • Chronic Myeloproliferative Disorders
  • +10 more
  • anti-thymocyte globulin
  • +12 more
  • Phoenix, Arizona
  • +1 more
Sep 3, 2014

Chronic Graft-vs.-Host Disease Trial in Boston (Alemtuzumab (Campath))

Completed
Has Results
  • Chronic Graft-vs.-Host Disease
  • Alemtuzumab (Campath)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 7, 2013

Chronic Graft-versus-host Disease Trial in Boston, Seattle, Milwaukee (Alefacept)

Terminated
Has Results
  • Chronic Graft-versus-host Disease
  • Boston, Massachusetts
  • +2 more
Aug 11, 2013

GVHD Trial in Italy (polyclonal antibody, Rituximab, Treosulfan)

Unknown status
  • Graft Versus Host Disease
  • polyclonal antibody
  • +6 more
  • Cagliari, Italy
  • +3 more
Mar 12, 2013

Chronic Graft-versus-host Disease Trial in Guangzhou (Mesenchymal stem cells, Non-mesenchymal stem cells)

Unknown status
  • Chronic Graft-versus-host Disease
  • Mesenchymal stem cells
  • Non-mesenchymal stem cells
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jan 8, 2013

Chronic GVHD Trial in Nashville (LBH589, Methylprednisolone)

Withdrawn
  • Chronic Graft-Versus-Host Disease
  • Nashville, Tennessee
    Tennessee Oncology, PLLC
Feb 11, 2013

Experience of Having Chronic Graft-Versus-Host Disease

Completed
  • Graft-Versus-Host Disease
  • Interview
  • Questionnaire
  • Buffalo, New York
  • +1 more
Jul 27, 2012

GVHD, Oral Manifestations Trial in Campinas, Rio de Janeiro (Clobetasol, Dexamethasone)

Completed
  • Graft vs Host Disease
  • Oral Manifestations
  • Campinas, São Paulo, Brazil
  • +1 more
Sep 30, 2012

Lymphoma Trial in United States (procedure, drug, radiation)

Terminated
Has Results
  • Lymphoma
  • Extracorporeal Photopheresis
  • +6 more
  • Aurora, Colorado
  • +18 more
Feb 11, 2013

Chronic GVHD Trial in Hangzhou (Biological: mesenchymal stem cell, Cyclosporine and Glucocorticoid)

Unknown status
  • Chronic Graft Versus Host Disease
  • Biological: mesenchymal stem cell
  • Cyclosporine and Glucocorticoid
  • Hangzhou, Zhejiang, China
    Zhejiang University
Aug 1, 2012

GVHD, Alogenic Hematopoietic Transplant Trial in Houston (Rituximab)

Withdrawn
  • Graft vs Host Disease
  • Alogenic Hematopoietic Transplant
  • Houston, Texas
  • +1 more
Jul 6, 2012

GVHD Trial in Calgary, Vancouver, Toronto (Rituximab)

Terminated
  • Graft Versus Host Disease
  • Calgary, Alberta, Canada
  • +2 more
Sep 6, 2011

Leukemia, MDS Trial in Portland, Seattle (fludarabine, treosulfan, allogeneic blood or bone marrow transplantation)

Completed
Has Results
  • Leukemia
  • Myelodysplastic Syndromes
  • Portland, Oregon
  • +2 more
May 24, 2012

Breast Cancer Trial in Houston (Fludarabine, Melphalan, Stem Cell Infusion)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Aug 1, 2012

GVHD Trial in Freiburg (ATG-Fresenius S)

Completed
  • Graft vs Host Disease
  • ATG-Fresenius S
  • Freiburg, Baden-Württemberg, Germany
    Universität Freiburg, Medizinische Klinik, Abteilung Innere Medi
Dec 9, 2011

GVHD, Solid Tumor, Child Solid Tumor Trial in United States (thalidomide)

Completed
  • Graft Versus Host Disease
  • +2 more
  • Little Rock, Arkansas
  • +9 more
Mar 3, 2011

GVHD Trial in Korea, Republic of (Itraconazole)

Terminated
  • Graft vs Host Disease
  • Hwasun, Jeollanam-do, Korea, Republic of
  • +8 more
Jan 24, 2011

Hematologic Malignancies Trial in Canada (Anti-Thymocyte Globulin (Rabbit), Patients will receive a standard preparative regimen

Unknown status
  • Hematologic Malignancies
  • Anti-Thymocyte Globulin (Rabbit)
  • Patients will receive a standard preparative regimen (i.e. one that does not contain Thymoglobulin)
  • Vancouver, British Columbia, Canada
  • +9 more
Oct 7, 2010

Oral Chronic GVHD Trial in Boston (Narrow-Band UVB Phototherapy)

Terminated
  • Oral Chronic Graft-Versus-Host Disease
  • Narrow-Band UVB Phototherapy
  • Boston, Massachusetts
  • +1 more
Mar 17, 2010

Clinical and Histological Correlation of Oral

Completed
  • Graft-Versus-Host Disease
  • oral biopsy
  • (no location specified)
May 11, 2009